85.74 USD
-1.25 (-1.44%)
85.74 USD
0 (0%)
Taking everything into account, LMAT scores 7 out of 10 in our fundamental rating. LMAT was compared to 186 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a decent growth rate and is not valued too expensively. These ratings would make LMAT suitable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year LMAT was profitable.
- In the past year LMAT had a positive cash flow from operations.
- LMAT had positive earnings in each of the past 5 years.
- LMAT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 8.92%, LMAT belongs to the best of the industry, outperforming 91.40% of the companies in the same industry.
- The Return On Equity of LMAT (14.08%) is better than 90.32% of its industry peers.
- LMAT has a Return On Invested Capital of 8.43%. This is amongst the best in the industry. LMAT outperforms 87.10% of its industry peers.
- LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 8.84%.
- The last Return On Invested Capital (8.43%) for LMAT is above the 3 year average (8.26%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
- The Profit Margin of LMAT (22.14%) is better than 94.09% of its industry peers.
- In the last couple of years the Profit Margin of LMAT has grown nicely.
- LMAT has a better Operating Margin (25.71%) than 95.16% of its industry peers.
- LMAT's Operating Margin has improved in the last couple of years.
- LMAT has a better Gross Margin (70.97%) than 79.57% of its industry peers.
- LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
- Compared to 1 year ago, LMAT has more shares outstanding
- LMAT has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for LMAT is higher compared to a year ago.
2.2 Solvency
- LMAT has an Altman-Z score of 7.40. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of LMAT (7.40) is better than 85.48% of its industry peers.
- The Debt to FCF ratio of LMAT is 2.54, which is a good value as it means it would take LMAT, 2.54 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 2.54, LMAT belongs to the top of the industry, outperforming 84.41% of the companies in the same industry.
- A Debt/Equity ratio of 0.44 indicates that LMAT is not too dependend on debt financing.
- LMAT has a Debt to Equity ratio of 0.44. This is comparable to the rest of the industry: LMAT outperforms 45.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.4 |
ROIC/WACC0.85
WACC9.94%
2.3 Liquidity
- A Current Ratio of 13.58 indicates that LMAT has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 13.58, LMAT belongs to the best of the industry, outperforming 97.85% of the companies in the same industry.
- A Quick Ratio of 11.45 indicates that LMAT has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 11.45, LMAT belongs to the top of the industry, outperforming 95.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
- LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.67%, which is quite good.
- LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
- Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.07% in the last year.
- Measured over the past years, LMAT shows a quite strong growth in Revenue. The Revenue has been growing by 13.41% on average per year.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
- Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.10% on average per year.
- Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.65% on average per year.
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 39.15, which means the current valuation is very expensive for LMAT.
- Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
- LMAT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.32.
- A Price/Forward Earnings ratio of 32.49 indicates a quite expensive valuation of LMAT.
- Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 72.04% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.32, LMAT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.15 | ||
| Fwd PE | 32.49 |
4.2 Price Multiples
- LMAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 75.81% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, LMAT is valued cheaper than 81.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.38 | ||
| EV/EBITDA | 20.51 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of LMAT may justify a higher PE ratio.
- LMAT's earnings are expected to grow with 14.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.42
PEG (5Y)2.29
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.92%, LMAT is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.19, LMAT pays a better dividend. On top of this LMAT pays more dividend than 92.47% of the companies listed in the same industry.
- With a Dividend Yield of 0.92, LMAT pays less dividend than the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
5.2 History
- The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
- LMAT has paid a dividend for at least 10 years, which is a reliable track record.
- LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
- LMAT pays out 32.20% of its income as dividend. This is a sustainable payout ratio.
- The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
85.74
-1.25 (-1.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners95.2%
Inst Owner Change4.07%
Ins Owners7.98%
Ins Owner Change-4.55%
Market Cap1.95B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target105.74 (23.33%)
Short Float %5.56%
Short Ratio6.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.92% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.64%
PT rev (3m)-1.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.33%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)6.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.15 | ||
| Fwd PE | 32.49 | ||
| P/S | 8.08 | ||
| P/FCF | 29.38 | ||
| P/OCF | 26.55 | ||
| P/B | 5.13 | ||
| P/tB | 6.92 | ||
| EV/EBITDA | 20.51 |
EPS(TTM)2.19
EY2.55%
EPS(NY)2.64
Fwd EY3.08%
FCF(TTM)2.92
FCFY3.4%
OCF(TTM)3.23
OCFY3.77%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.42
PEG (5Y)2.29
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.4 |
F-Score5
WACC9.94%
ROIC/WACC0.85
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a valuation rating of 5 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 39.15 and the Price/Book (PB) ratio is 5.13.
How financially healthy is LEMAITRE VASCULAR INC?
The financial health rating of LEMAITRE VASCULAR INC (LMAT) is 7 / 10.